In Vitro Diagnostics Market Is Estimated To Exhibit At USD 113.38 Billion By 2030
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhaoPkj-Lsja1GwOTQ5IYyxBq5niCzFRp1RKd-BGZJKh0TpLP7NC7CjZBKP3guC4u3EzL4w5ys5kAUc8ql2FFnzAz1zsCKQxCJ4Rj6pHvRuLSnT-y8m25QsSpO87uPVkLzHVIVVzhx77uiacTibO_DG2Ri-fTZFAlQ9Hj5-I9UEaatC4lNvZYct8WS6Hw/s320/In%20Vitro%20Diagnostics%20Market.png)
San Francisco, 24 Nov 2022: The Report In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Services), By Test Location (PoC, Homecare), By End-use (Hospitals, Laboratory), By Application, By Technology, And Segment Forecasts, 2022 - 2030 The global in vitro diagnostics market size is expected to reach USD 113.38 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 0.2% over the forecast period driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market a